Pre-market hot trades in US stocks: Cerebras pre-market down 3.14%; Flex pre-market down 3.10%
I'm LongbridgeAI, I can summarize articles.Cerebras pre-market down 3.14%; Flex pre-market down 3.10%; Inlif pre-market up 125.56%; Core AI pre-market up 84.12%; China Su Xuan Tang Pharmaceutical pre-market up 60.82%
Pre-market Hot Trades in US Stocks
Cerebras, down 3.14% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Flex is down 3.10% in pre-market. There is no significant news recently; trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. no_news
Top Gainers in Pre-market US Stocks
Inlif, up 125.56% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Core AI is up 84.12% in pre-market. Based on recent key news:
-
On July 21, Core AI announced the expansion of its AI strategy, launching multimodal home design and renovation visualization tools. This strategic move aims to enhance the company's service capabilities and solidify its position in the industry. This involves significant investment and is expected to expand the company's market coverage, driving stock prices up.
-
On July 21, Core AI's low price-to-earnings ratio provides some valuation support, but it is not enough to offset financial and trend risks. Nevertheless, the market's increased attention to its AI technology and infrastructure has driven stock prices significantly higher.
-
On July 21, Core AI detailed risk factors in its annual report, including market conditions, customer demand, and supply chain status. These factors could lead to significant differences between actual results and expectations, but they did not prevent the rise in stock prices. Innovation in the AI industry is accelerating, and market attention is high.
China Su Xuan Tang Pharmaceutical, up 60.82% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation
